Cargando…
Application of extracorporeal therapies in critically ill COVID-19 patients
The coronavirus disease 2019 (COVID-19) pandemic is a major public health event caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 has spread widely all over the world. A high proportion of patients become severely or critically ill, and suffer high mortality due to res...
Autores principales: | ZHOU, Zhifeng, KUANG, Huang, MA, Yuexian, ZHANG, Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Zhejiang University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435342/ https://www.ncbi.nlm.nih.gov/pubmed/34514751 http://dx.doi.org/10.1631/jzus.B2100344 |
Ejemplares similares
-
The role of extracorporeal membrane oxygenation in critically ill patients with COVID-19: a narrative review
por: Huang, Shiqian, et al.
Publicado: (2021) -
Extracorporeal endotoxin adsorbent therapy in the critically ill patients with COVID-19 during ECMO
por: Fu, Bao, et al.
Publicado: (2023) -
Extracorporeal endotoxin adsorbent therapy in the critically ill patients with COVID-19 during ECMO
por: Fu, Bao, et al.
Publicado: (2023) -
Current Applications for the Use of Extracorporeal Carbon Dioxide Removal in Critically Ill Patients
por: Camporota, Luigi, et al.
Publicado: (2016) -
Initial evaluation of extracorporeal immunomodulatory therapy for the treatment of critically ill COVID-19 infected patients
por: Lemoine, Sandrine, et al.
Publicado: (2022)